SEATTLE GENETICSClinical Trial Agreement • October 17th, 2018
Contract Type FiledOctober 17th, 2018This Clinical Trial Agreement (the “Agreement”) is made as of the day the last party to subscribe below (the “Effective Date”) by and between
SEATTLE GENETICSClinical Trial Agreement • December 14th, 2016
Contract Type FiledDecember 14th, 2016CLINICAL TRIAL AGREEMENT SMLOUVA O KLINICKÉM HODNOCENÍ This Clinical Trial Agreement (the “Agreement”) is made as of 2 March 2016 (the “Effective Date”) by and between Seattle Genetics, Inc., a Delaware corporation, located at 21823 30th Drive SE, Bothell, Washington 98021 USA, (the “Company”), which has authorized Seattle Genetics UK, Ltd., located at 20-22, Bedford Row, London, WC1 R 4JS, as its legal represenatative, and Pharmaceutical Research Associates CZ, s.r.o., located at Praha 7, Jankovcova 1569/2c, Post Code (PSČ): 170 00, Czech Republic, Company ID number (IČ): 27636852, the limited liability company duly registered in the Commercial Register of the Czech Republic maintained by the Municipal Court in Prague, Section C, Entry 120574, represented by MUDr. Andrea Klč, Proxy (“CRO”) as clinical research organization acting as an independent contractor of Company, and Fakultní nemocnice Brno, located at Jihlavská 20, Post Code 62500, Brno, Czech Republic, Company ID number (IČ